For more than 60 years, Medela has been dedicated to advancing breastfeeding and lactation through science, research, education, and innovative solutions. In order to strengthen this focus and ensure alignment with the World Health Organization's International Code of Marketing of Breast Milk Substitutes, Medela is making a pivotal change to its portfolio.
By July 1, 2025, Medela will discontinue the sale of feeding bottles and teats. Production and sourcing have already ceased, and the manufacturing of pacifiers ended in November 2024. These changes reflect our unwavering commitment to prioritizing breastfeeding and lactation support.
This decision, led by Chairman Michael Larsson, CEO Thomas Golücke, and fully supported by the Board of Directors and Group Management, reaffirms Medela’s mission to champion breastfeeding globally. By removing products that might fall within the scope of the WHO Code, Medela strengthens its collaboration with the research, breastfeeding, and lactation communities.
We remain focused on supporting breastfeeding families worldwide, ensuring that every baby has access to breast milk – the best possible nutrition for a strong start in life – while pursuing this goal with clarity, care and dedication. As part of this commitment, we empower mothers and families with innovative solutions and support in breast pumps and breast care while addressing challenges such as achieving a full milk supply and successful direct breastfeeding.
We firmly support mothers in making informed decisions about how they feed their babies — regardless of how their journey looks. While we will no longer offer feeding bottles and teats, we recognize that there are many options available on the market to meet diverse needs and preferences. Medela will continue to provide medical and specialty feeding options such as Supplemental Nursing Systems, Special Needs Feeders, Soft Cups, Baby Cup feeders, FingerFeeders, and enteral feeding solutions — ensuring that babies with feeding issues have access to the best products.